chromazonarol has been researched along with 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide in 1 studies
*2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide: an industrial fungicide [MeSH]
*2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide: an industrial fungicide [MeSH]
Studies (chromazonarol) | Trials (chromazonarol) | Recent Studies (post-2010) (chromazonarol) | Studies (2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide) | Trials (2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide) | Recent Studies (post-2010) (2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide) |
---|---|---|---|---|---|
7 | 0 | 2 | 16 | 0 | 14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, N; Kong, W; Li, S; Song, B; Wang, X | 1 |
1 other study(ies) available for chromazonarol and 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide
Article | Year |
---|---|
Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
Topics: Antifungal Agents; Ascomycota; Dose-Response Relationship, Drug; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Structure; Rhizoctonia; Stereoisomerism; Structure-Activity Relationship; Xanthenes | 2022 |